Newsletter
Episode 118 – Jessica DaMassa & Matthew Holt: Omicron & Other Variants

CareTalk

Episode 118 – Jessica DaMassa & Matthew Holt: Omicron & Other Variants

November 30, 2021

Episode 118 – Jessica DaMassa & Matthew Holt: Omicron & Other Variants

Jessica Damassa and Matthew Holt, hosts of the Health in 2 Point 00 Podcast, join the show to discuss the Omicron variant, high digital health company valuations, climate change and much, much more.

Visit us at www.caretalkpodcast.com

Subscribe to CareTalk on your favorite podcast service:
Spotify https://open.spotify.com/show/2GTYhbN……
Apple Podcasts https://podcasts.apple.com/us/podcast……
Google Podcasts https://podcasts.google.com/feed/aHR0……

Follow us on the Health Podcast Network: https://bit.ly/3Glciwj
Watch this episode on YouTube: https://youtu.be/lstAKZz08pQ

About Jessica Damassa:
Jessica Damassa is the Exec. Producer and host of ‘WTF Health – What’s the Future, Health?', an interview series taking her around the world to 17 different health tech conferences in 11 different countries to continue her quest of asking everyone everywhere about the future of health – and what is wrong with it right now. She also co-hosts the podcast Health in 2 Point 00, which airs on The Health Care Blog with editorial commentary and analysis on the latest stories shaping the health tech market.

About Matthew Holt:
Matthew Holt has spent many years in health care as a researcher, forecaster, and strategist. He has conducted in-depth studies about many aspects of health care for public release and private clients. He is the founder of The Health Care Blog, where he publishes his analysis and opinions about health care. He is also the co-host of the Health in 2 Point 00 podcast.

#healthcaretechnology #health #omnicronvariant #digitalhealth #healthcareindustry #healthcareinnovation

You may also like

Top Health Podcasts. Delivered to Your Inbox and Eardrums.

Join Our Newsletter

Proudly supported by:

cover
Episode #123 – Is It Getting Worse to Be a Nurse? John and David tackle the shortage, while exploring the implications it can have for our healthcare system as a whole.